JP2016518358A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518358A5
JP2016518358A5 JP2016507694A JP2016507694A JP2016518358A5 JP 2016518358 A5 JP2016518358 A5 JP 2016518358A5 JP 2016507694 A JP2016507694 A JP 2016507694A JP 2016507694 A JP2016507694 A JP 2016507694A JP 2016518358 A5 JP2016518358 A5 JP 2016518358A5
Authority
JP
Japan
Prior art keywords
composition
active agent
poly
composition according
predetermined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016507694A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518358A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/033873 external-priority patent/WO2014169256A2/en
Publication of JP2016518358A publication Critical patent/JP2016518358A/ja
Publication of JP2016518358A5 publication Critical patent/JP2016518358A5/ja
Pending legal-status Critical Current

Links

JP2016507694A 2013-04-11 2014-04-11 ポリプレックス Pending JP2016518358A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361811078P 2013-04-11 2013-04-11
US61/811,078 2013-04-11
PCT/US2014/033873 WO2014169256A2 (en) 2013-04-11 2014-04-11 Polyplexes

Publications (2)

Publication Number Publication Date
JP2016518358A JP2016518358A (ja) 2016-06-23
JP2016518358A5 true JP2016518358A5 (enExample) 2017-05-25

Family

ID=51690135

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016507694A Pending JP2016518358A (ja) 2013-04-11 2014-04-11 ポリプレックス

Country Status (12)

Country Link
US (1) US10835549B2 (enExample)
EP (1) EP2991616A4 (enExample)
JP (1) JP2016518358A (enExample)
KR (1) KR20150143639A (enExample)
CN (1) CN105431134A (enExample)
AU (1) AU2014250830A1 (enExample)
BR (1) BR112015025968A2 (enExample)
CA (1) CA2911315A1 (enExample)
HK (1) HK1216152A1 (enExample)
MX (1) MX2015014354A (enExample)
RU (1) RU2015148055A (enExample)
WO (1) WO2014169256A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3242886A4 (en) 2015-01-08 2018-08-29 Moerae Matrix, Inc., Formulation of mk2 inhibitor peptides
CN104815333B (zh) * 2015-04-05 2017-10-31 北京工业大学 一种聚离子胶束纳米粒子的制备方法及其应用
US11147827B2 (en) 2016-08-05 2021-10-19 Vanderbilt University Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004535388A (ja) * 2001-04-30 2004-11-25 ターゲティッド ジェネティクス コーポレイション 脂質含有薬物送達複合体およびそれらの生成方法
WO2003070823A2 (en) * 2002-02-20 2003-08-28 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
CA2513072A1 (en) * 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
JP5703466B2 (ja) * 2007-08-07 2015-04-22 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ キナーゼ阻害薬およびその使用
US9271933B2 (en) * 2007-11-27 2016-03-01 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
US20110060123A1 (en) * 2008-04-30 2011-03-10 Kazunori Kataoka Charge conversional ternary polyplex
US20100150952A1 (en) * 2008-11-07 2010-06-17 University Of Washington pH-RESPONSIVE POLYMER CARRIER COMPOSITIONS FOR CYTOSOLIC PROTEIN DELIVERY
CA2744104C (en) * 2008-12-10 2017-07-18 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
US20130115256A1 (en) * 2010-05-24 2013-05-09 Cynthia Lander Methods for treating or preventing vascular graft failure
CN115957297A (zh) 2013-03-15 2023-04-14 节奏制药公司 药物组合物

Similar Documents

Publication Publication Date Title
Pandey et al. Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery
Lee et al. Polymeric protein delivery systems
MX364396B (es) Poli(beta-amino esteres) modificados para suministro de farmaco.
Faya et al. Conjugates and nano-delivery of antimicrobial peptides for enhancing therapeutic activity
Nguyen et al. Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine
Shim et al. Graphene-based nanosheets for delivery of chemotherapeutics and biological drugs
Milcovich et al. Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot
FI3694529T3 (fi) Trispesifiset proteiinit ja niiden käyttömenetelmät
WO2017143042A3 (en) Compositions for enhancing targeted gene editing and methods of use thereof
Yang et al. Design of smart HPMA copolymer-based nanomedicines
HK1252759A1 (zh) 肽寡核苷酸缀合物
WO2019006471A3 (en) NOVEL CRISPR RNA TARGETING ENZYMES, SYSTEMS AND USES THEREOF
HK1251257A1 (zh) 用於医治疾病的外泌体的用途
AR071239A1 (es) Microesferas que tienen una estructura de nucleo / recubrimiento que comprenden aripiprazol y uso
JP2018502956A5 (enExample)
JP2011520813A5 (enExample)
JP2018510879A5 (enExample)
JP2017514800A5 (enExample)
JP2018519835A5 (enExample)
AR093013A1 (es) Proceso de mezclado sin uso de solventes para el recubrimiento de ingredientes farmaceuticos
JP2016518358A5 (enExample)
PE20091829A1 (es) Encapsulacion de agentes biologicamente activos
WO2016073905A8 (en) Microneedle arrays for cancer therapy applications
WO2016081835A3 (en) Targeted structure-specific particulate delivery systems
RU2016149734A (ru) Направленно доставляемые терапевтические наночастицы и способы их получения и использования